CPT1A and metabolic dysfunction-associated steatotic liver disease: While HFD-fed LKO mice displayed decreased Cpt1a expression and AMPK phosphorylation, KPA treatment in HFD-fed mice increased the expression of Cpt1a and AMPK activation and protected against NAFLD.